Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6066769 | Journal of Allergy and Clinical Immunology | 2012 | 8 Pages |
Abstract
Increased versus normal exhaled NO during outpatient exacerbation in patients with moderate-to-severe asthma on inhaled corticosteroid and long-acting β2-agonist but not maintenance oral corticosteroid does not preclude a robust clinical and spirometric response to tapering oral prednisone.
Keywords
Related Topics
Life Sciences
Immunology and Microbiology
Immunology
Authors
Arthur F. MD, Roxanna Moridzadeh, Deepak H. BS, Christine RCP, CPFT, Steven C. MD, PhD,